Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.52 |
| ▸ | PRKDC | P78527 | 7/20 | 0.42 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.40 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.38 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.37 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.34 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.34 |
| ▸ | BACE1 | P56817 | 1/20 | 0.32 |
| ▸ | CDC14B | O60729 | 2/20 | 0.32 |
| ▸ | CDC14A | Q9UNH5 | 2/20 | 0.32 |
| ▸ | AHR | P35869 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17875724 | 0.95 | ALOX5 (0.48) | ALOX5PRKDCGGPS1PTGES2PRMT5 | |
| SCHEMBL17875742 | 0.95 | ALOX5 (0.48) | ALOX5PRKDCGGPS1PTGES2PRMT5 | |
| SCHEMBL17875808 | 0.94 | ALOX5 (0.58) | ALOX5PRKDCGGPS1PTGES2PRMT5 | |
| SCHEMBL17875804 | 0.92 | ALOX5 (0.40) | ALOX5PRKDCBACE1CDC14BCDC14A | |
| SCHEMBL17875779 | 0.90 | ALOX5 (0.52) | ALOX5PRKDCGGPS1PTGES2PRMT5 | |
| SCHEMBL17875811 | 0.90 | ALOX5 (0.52) | ALOX5PRKDCGGPS1PTGES2PRMT5 | |
| SCHEMBL17875722 | 0.89 | ALOX5 (0.53) | ALOX5PRKDCGGPS1PTGES2PRMT5 | |
| SCHEMBL17875814 | 0.89 | ALOX5 (0.39) | ALOX5PRKDCATMBACE1AHR | |
| SCHEMBL17875786 | 0.89 | ALOX5 (0.39) | ALOX5PRKDCBACE1AHR | |
| SCHEMBL17875745 | 0.88 | ALOX5 (0.36) | ALOX5PRKDCBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10581000-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-03-03 | — | — | US | disclosed |
| US-20160190482-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
| US-20160190482-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10581000-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CRY2, CCNE2 | ALOX5 3059/4885PRKDC 4858/4885GGPS1 1622/4885 |
| US-20160190482-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | ALOX5 3059/4885PRKDC 4858/4885GGPS1 1622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.